BMS-564929 is a novel, highly potent, orally active, nonsteroidal tissue selective androgen receptor (AR) modulator, and this compound has been advanced to clinical trials for the treatment of age-related functional decline.
More Information Supplier PageBMS-564929 is a novel, highly potent, orally active, nonsteroidal tissue selective androgen receptor (AR) modulator, and this compound has been advanced to clinical trials for the treatment of age-related functional decline.
More Information Supplier PageBMS-564929 is a novel, highly potent, orally active, nonsteroidal tissue selective androgen receptor (AR) modulator, and this compound has been advanced to clinical trials for the treatment of age-related functional decline.
More Information Supplier PageEribulin mesylate is the mesylate salt of a synthetic analogue of halichondrin B, a substance derived from a marine sponge (Lissodendoryx sp.) with antineoplastic activity.
More Information Supplier PageGSK2578215A is a potent leucine-rich repeat kinase 2 (LRRK2) inhibitor (IC50 values are 8.9 and 10.1 nM respectively for LRRK2[G2019S] mutant and wild-type LRRK2 respectively).
More Information Supplier PageGSK2578215A is a potent leucine-rich repeat kinase 2 (LRRK2) inhibitor (IC50 values are 8.9 and 10.1 nM respectively for LRRK2[G2019S] mutant and wild-type LRRK2 respectively).
More Information Supplier PageMiglustat hydrochloride is an orally active ??-glucosidase I and II and ceramide-specific glycosyltransferase inhibitor.
More Information Supplier PageMiglustat hydrochloride is an orally active ??-glucosidase I and II and ceramide-specific glycosyltransferase inhibitor.
More Information Supplier PageMiglustat hydrochloride is an orally active ??-glucosidase I and II and ceramide-specific glycosyltransferase inhibitor.
More Information Supplier PageMiglustat hydrochloride is an orally active ??-glucosidase I and II and ceramide-specific glycosyltransferase inhibitor.
More Information Supplier Page
